NEW YORK, Sept. 22, 2005 (PRIMEZONE) -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(r) (EIO(r)) on Costa Mesa, California-based Synthetic Blood International, Inc. (OTCBB:SYBD). The full 40-page report can be found at www.crystalra.com, or through a link located in the Investor Relations section of the Company's website at www.sybd.com. This report was paid for by Synthetic Blood International, Inc.
Synthetic Blood International, Inc. is a biomedical product development company specializing in creating innovative pharmaceuticals and medical devices in the fields of oxygen therapeutics and continuous biosensor monitors. The Company is developing a blood substitute and a liquid ventilation product as well as an implantable glucose monitor. These products are based on core technologies that include biomedical applications for perfluorocarbons (PFCs) and medical and industrial applications for biosensors.
Synthetic Blood's lead candidate, Oxycyte(tm), is being developed as an alternative to transfused blood for use in surgical and similar medical situations. Oxycyte(tm) is an oxygen-carrying intravenous emulsion that can carry three to four times more oxygen than hemoglobin. Therapeutic oxygen carriers have shown promise in the treatment of such ischemic conditions as heart disease, cancer, stroke, traumatic brain injury, sickle cell anemia, decompression sickness (bends), and carbon monoxide poisoning.
About Crystal Research Associates, LLC
Crystal Research Associates, LLC is an independent research firm that provides institutional-quality fee-based research to small and mid-cap companies. The Company's unique and novel product, the Executive Informational Overview(r) (EIO(r)), is free of investment ratings, target prices, and forward-looking financial models. The EIO(r) presents a crystal-clear, detailed report on a company (whether public or private) in a manner that is easily understood by the Wall Street financial community. The EIO(r) details a company's product/technology/service offerings, market size(s), key intellectual property (IP), leadership, growth strategy, competition, risks, audited financial statements, key events and other such fundamental information. Crystal Research Associates has offices in New York City, Delray Beach, Montreal, and Toronto. Please see back of report for complete Company disclosures.
Forward-Looking Safe Harbor Statement
To the extent that this release discusses any expectations concerning future plans, financial results or performance, such statements are forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, and are subject to substantial risks and uncertainties. Actual results could differ materially from those anticipated in the forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and reflect only management's belief and expectations based upon presently available information. These statements, and other forward-looking statements, are not guarantees of future performance and involve risks and uncertainties. Crystal Research Associates, LLC assumes no obligation to update any of the forward-looking statements in this release.